Back to Search Start Over

Investigators at Janssen Research & Development LLC Report Findings in Crohn's Disease (Model-based Investigation of Inadequate Efficacy of Tesnatilimab, an Anti-natural Killer Group 2 Member D Monoclonal Antibody, In Moderately To Severely ...)

Source :
Obesity, Fitness & Wellness Week. June 17, 2023, 117
Publication Year :
2023

Abstract

2023 JUN 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Digestive System Diseases and Conditions - Crohn's Disease have [...]

Details

Language :
English
ISSN :
15316386
Database :
Gale General OneFile
Journal :
Obesity, Fitness & Wellness Week
Publication Type :
Periodical
Accession number :
edsgcl.752604105